GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » Equity-to-Asset

Medicus Pharma (Medicus Pharma) Equity-to-Asset : 0.43 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Medicus Pharma's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $0.81 Mil. Medicus Pharma's Total Assets for the quarter that ended in Dec. 2023 was $1.89 Mil.

The historical rank and industry rank for Medicus Pharma's Equity-to-Asset or its related term are showing as below:

MDPLF' s Equity-to-Asset Range Over the Past 10 Years
Min: -133.15   Med: -43.15   Max: 0.43
Current: 0.43

During the past 3 years, the highest Equity to Asset Ratio of Medicus Pharma was 0.43. The lowest was -133.15. And the median was -43.15.

MDPLF's Equity-to-Asset is ranked worse than
68.35% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs MDPLF: 0.43

Medicus Pharma Equity-to-Asset Historical Data

The historical data trend for Medicus Pharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma Equity-to-Asset Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23
Equity-to-Asset
-132.99 -43.10 0.43

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only -43.10 -352.28 -85.53 0.69 0.43

Competitive Comparison of Medicus Pharma's Equity-to-Asset

For the Drug Manufacturers - General subindustry, Medicus Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicus Pharma's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicus Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Medicus Pharma's Equity-to-Asset falls into.



Medicus Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Medicus Pharma's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0.806/1.893
=

Medicus Pharma's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0.806/1.893
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicus Pharma  (OTCPK:MDPLF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Medicus Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicus Pharma (Medicus Pharma) Business Description

Comparable Companies
Traded in Other Exchanges
Address
100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire 10-26-2023